Activation of the TCA Cycle to Provide Immune Protection in Zebrafish Immunized by High Magnesium-Prepared Vibrio alginolyticus Vaccine

Vaccines are safe and efficient in controlling bacterial diseases in the aquaculture industry and are in line with green farming. The present study develops a previously unreported approach to prepare a live-attenuated vaccine by culturing bacteria in a high concentration of magnesium to attenuate b...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in immunology Vol. 12; p. 739591
Main Authors Yang, Jun, Yang, Xiao-Li, Su, Yu-Bin, Peng, Xuan-Xian, Li, Hui
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Media S.A 07.12.2021
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Vaccines are safe and efficient in controlling bacterial diseases in the aquaculture industry and are in line with green farming. The present study develops a previously unreported approach to prepare a live-attenuated vaccine by culturing bacteria in a high concentration of magnesium to attenuate bacterial virulence. Furthermore, metabolomes of zebrafish immunized with the live-attenuated vaccines were compared with those of survival and dying zebrafish infected by . The enhanced TCA cycle and increased fumarate were identified as the most key metabolic pathways and the crucial biomarker of vaccine-mediated and survival fish, respectively. Exogenous fumarate promoted expression of , , , , and lysozyme in a dose-dependent manner. Among the five innate immune genes, the elevated , , and are overlapped in the vaccine-immunized zebrafish and the survival from the infection. These findings highlight a way in development of vaccines and exploration of the underlying mechanisms.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Edited by: Julia Kzhyshkowska, Heidelberg University, Germany
This article was submitted to Vaccines and Molecular Therapeutics, a section of the journal Frontiers in Immunology
Reviewed by: Jose Alejandro Chabalgoity, University of the Republic, Uruguay; Ganesh Ram Visweswaran, Seattle Children’s Hospital, United States
ISSN:1664-3224
1664-3224
DOI:10.3389/fimmu.2021.739591